GlassScriptPhysician profile
Nimidia Oviedo
NPI 1770592438
$13,445.03
in general payments reported to CMS, 2019-2025
32 companies · $1,918 in 2025
The $1,918 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,859 · 2020: $1,508 · 2021: $1,757 · 2022: $1,615 · 2023: $1,771 · 2024: $2,017 · 2025: $1,918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,706.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,950.78 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $1,745.24 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,400.39 | 2019-2025 | Jardiance, Spiriva, Synjardy |
| Astrazeneca Pharmaceuticals LP | $1,168.32 | 2019-2025 | Lokelma, Airsupra, Farxiga |
| Glaxosmithkline, LLC. | $1,095.17 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Daiichi Sankyo INC. | $782.67 | 2019-2025 | Injectafer, Vanflyta |
| Astellas Pharma US INC | $763.60 | 2019-2025 | Veozah |
| Lilly USA, LLC | $756.07 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amarin Pharma, INC. | $616.57 | 2019-2023 | |
| Viiv Healthcare Company | $601.30 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $524.63 | 2019-2025 | |
| Abbvie INC. | $285.86 | 2021-2025 | |
| Abbott Laboratories | $260.97 | 2019-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $240.27 | 2024-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $209.39 | 2021-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $160.84 | 2019-2023 | |
| Gilead Sciences, INC. | $157.34 | 2019 | |
| Exact Sciences Corporation | $148.89 | 2024-2025 | Cologuard Collection Kit |
| Pfizer INC. | $92.30 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $73.00 | 2023 | |
| Merck Sharp & Dohme LLC | $66.80 | 2019-2020 | |
| Amgen INC. | $66.78 | 2021-2025 | Repatha, Otezla, Evenity |
| Kowa Pharmaceuticals America, INC. | $47.76 | 2021-2022 | |
| Verona Pharma, INC. | $46.64 | 2025 | Ohtuvayre |
| Medtronic Minimed, INC. | $43.80 | 2019-2020 | |
| Allergan, INC. | $33.09 | 2019 | |
| Biotronik INC. | $20.00 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $18.75 | 2020 | |
| Hologic Sales and Service, LLC | $17.99 | 2025 | Aptima |
| Boston Scientific Corporation | $17.89 | 2023 | Watchman Access System |
| Janssen Biotech, INC. | $17.32 | 2021 | |
| Azurity Pharmaceuticals, INC. | $14.61 | 2024 | Edarbyclor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nimidia Oviedo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.